Implications of acute coronavirus disease 2019 during haematopoietic stem cell transplantation—Experience from real‐world clinical practice

Documenti analoghi

• Prognostic Value of Geriatric Characteristics in Allogeneic Haematopoietic Stem Cell Transplant Recipients Aged Over 60 Years
  di: Xiu Hue Lee, et al.
  Pubblicazione: (2025)
• Graft‐versus‐host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
  di: Osamu Imataki, et al.
  Pubblicazione: (2024)
• Acquired glucose‐6‐phosphate dehydrogenase deficiency after allogeneic stem‐cell transplantation
  di: Quentin Vô, et al.
  Pubblicazione: (2024)
• Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors
  di: B. Linder Grønvold, et al.
  Pubblicazione: (2024)
• Combination of reduced post‐transplant cyclophosphamide and early tacrolimus initiation increases the incidence of chronic graft‐versus‐host disease in human leukocyte antigen‐haploidentical peripheral blood stem‐cell transplantation
  di: Toshiki Terao, et al.
  Pubblicazione: (2024)